These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26618660)

  • 1. Introduction of a new Rotavirus vaccine: Initial results of uptake and impact on laboratory confirmed cases in Anglia and Essex, United Kingdom, July 2015.
    Inns T; Trindall A; Dunling-Hall S; Shankar AG
    Hum Vaccin Immunother; 2016 Apr; 12(4):1040-4. PubMed ID: 26618660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.
    Nakagomi O; Iturriza-Gomara M; Nakagomi T; Cunliffe NA
    Expert Opin Biol Ther; 2013 Nov; 13(11):1613-21. PubMed ID: 24088009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in Severity of All-Cause Gastroenteritis Requiring Hospitalisation in Children Vaccinated against Rotavirus in Malawi.
    Mandolo JJ; Henrion MYR; Mhango C; Chinyama E; Wachepa R; Kanjerwa O; Malamba-Banda C; Shawa IT; Hungerford D; Kamng'ona AW; Iturriza-Gomara M; Cunliffe NA; Jere KC
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom.
    Marlow R; Muir P; Vipond B; Lyttle M; Trotter C; Finn A
    Euro Surveill; 2015; 20(48):30077. PubMed ID: 26675375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.
    Tsolenyanu E; Djadou KE; Fiawoo M; Akolly DAE; Mwenda JM; Leshem E; Tate JE; Aliabadi N; Koudema W; Guedenon KM; Godonou M; Dagnra A; Gbadoe AD; Boko A; Landoh D; Atakouma Y; Parashar UD
    Vaccine; 2018 Nov; 36(47):7185-7191. PubMed ID: 29397224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Parashar UD; Alexander JP; Glass RI;
    MMWR Recomm Rep; 2006 Aug; 55(RR-12):1-13. PubMed ID: 16902398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children.
    Sahakyan G; Grigoryan S; Wasley A; Mosina L; Sargsyan S; Asoyan A; Gevorgyan Z; Kocharyan K; Avagyan T; Lopman B; Vanyan A; Khactatryan S; Parashar UD; Cortese MM
    Clin Infect Dis; 2016 May; 62 Suppl 2():S147-54. PubMed ID: 27059349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.
    Isanaka S; Langendorf C; McNeal MM; Meyer N; Plikaytis B; Garba S; Sayinzoga-Makombe N; Soumana I; Guindo O; Makarimi R; Scherrer MF; Adehossi E; Ciglenecki I; Grais RF
    PLoS Med; 2021 Jul; 18(7):e1003655. PubMed ID: 34214095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
    Enane LA; Gastañaduy PA; Goldfarb DM; Pernica JM; Mokomane M; Moorad B; Masole L; Tate JE; Parashar UD; Steenhoff AP
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S168-74. PubMed ID: 27059352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.
    Hartwig S; Uhari M; Renko M; Bertet P; Hemming M; Vesikari T
    BMC Health Serv Res; 2014 Dec; 14():632. PubMed ID: 25494641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo.
    Tsolenyanu E; Mwenda JM; Dagnra A; Leshem E; Godonou M; Nassoury I; Landoh D; Tate JE; Atakouma Y; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S196-9. PubMed ID: 27059356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.
    Thomas SL; Walker JL; Fenty J; Atkins KE; Elliot AJ; Hughes HE; Stowe J; Ladhani S; Andrews NJ
    Vaccine; 2017 Jan; 35(4):680-686. PubMed ID: 28007397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.
    Bawa Z; Elliot AJ; Morbey RA; Ladhani S; Cunliffe NA; O'Brien SJ; Regan M; Smith GE
    Clin Infect Dis; 2015 Jul; 61(1):77-85. PubMed ID: 25828997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.
    Plosker GL
    Drugs; 2010 Jun; 70(9):1165-88. PubMed ID: 20518582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis.
    Middleton BF; Jones MA; Waddington CS; Danchin M; McCallum C; Gallagher S; Leach AJ; Andrews R; Kirkwood C; Cunliffe N; Carapetis J; Marsh JA; Snelling T
    BMJ Open; 2019 Nov; 9(11):e032549. PubMed ID: 31727664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
    Bar-Zeev N; Tate JE; Pecenka C; Chikafa J; Mvula H; Wachepa R; Mwansambo C; Mhango T; Chirwa G; Crampin AC; Parashar UD; Costello A; Heyderman RS; French N; Atherly D; Cunliffe NA;
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014.
    Sabbe M; Berger N; Blommaert A; Ogunjimi B; Grammens T; Callens M; Van Herck K; Beutels P; Van Damme P; Bilcke J
    Euro Surveill; 2016 Jul; 21(27):. PubMed ID: 27418466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.